Share

Osteoarthritis is a common condition that affects your joints and is frequently associated with aging. Today, we look at a new open-access paper that discusses the role of aging in the progression of this disease.

So, what is osteoarthritis?

Over time, the surfaces of your joints become worn and damaged, causing them to no longer move as smoothly as they should. Eventually, the cartilage protecting the ends of the bones at the joints gradually thins and eventually wears away, exposing the bone underneath.

This causes the bone to thicken and the tissues in the joint to become more active than normal as the body tries to repair the damage. This leads to the bone at the edge of the joint to grow outwards and form jagged spurs known as osteophytes.

This can cause the synovium (the inner layer of the joint capsule that produces synovial fluid) to thicken and produce excess fluid. The extra fluid can then cause the joint to swell, leading to inflammation and discomfort.

In severe cases, the cartilage can become so thin that the bones grind against each other and wear away. This wearing away of the bone and the formation of spurs can change the shape of a joint and force bones out of position.

Osteoarthritis and oxidative stress

We have talked about osteoarthritis and the role of senescent cells before in a previous article, and a clear link between senescent cell accumulation in joint tissue and the progression of osteoarthritis has been made. Perhaps more importantly, it has been shown that removing these accumulated dysfunctional cells may be beneficial in treating this condition [1].

The topic of osteoarthritis has appeared again in this new open-access paper [2]. The author of the paper focuses more on the role of oxidative stress rather than the inflammation caused by senescent cells, though the two are closely linked, with one being able to cause the other and vice versa [3].

Oxidative stress is caused by the excessive creation of reactive oxygen species (ROS) in cells, often by the mitochondria, and it can lead to damage of the cellular machinery or even destroy cells.

More often than not, oxidative stress and inflammation happen together and form a feedback loop, so while this paper focuses on oxidative stress, it offers a slightly different angle on the same large picture.

Mitochondrial dysfunction, cellular senescence, oxidative stress, and inflammation are bound together, and as you read the paper, you will see how interlinked these things are.

Conclusion

This year, Unity Biotechnology is running the first human trials of therapies designed to remove senescent cells, and osteoarthritis is on this company’s target list of diseases to treat, so we will hopefully soon be able to discern how these things interact with each other and to what extent one influences the other.

There are researchers working on the management of oxidative stress and even more ambitious projects such as MitoSENS, which is working to create copies of the mitochondrial genes in the cell nucleus, where they would be shielded from ROS damage. MitoSENS has already successfully moved some of these genes over and could offer a long-term solution to oxidative stress damage.

Also, with senescent cell-removing therapies known as senolytics already showing promising data for osteoarthritis in preclinical testing, there is some room for being optimistic about the potential of this approach in people. Will the results seen in animals translate to humans?

As always in science, the proof of the pudding is in the eating, so let’s find out!

Literature

[1] Jeon, O. H., Kim, C., Laberge, R. M., Demaria, M., Rathod, S., Vasserot, A. P., … & Baker, D. J. (2017). Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment. Nature medicine, 23(6), 775-781.

[2] LOESER, R. F. (2017). The Role of Aging in the Development of Osteoarthritis. Transactions of the American Clinical and Climatological Association, 128, 44.

[3] Salzano, S., Checconi, P., Hanschmann, E. M., Lillig, C. H., Bowler, L. D., Chan, P., … & Atkuri, K. R. (2014). Linkage of inflammation and oxidative stress via release of glutathionylated peroxiredoxin-2, which acts as a danger signal. Proceedings of the National Academy of Sciences, 111(33), 12157-12162.

About the author

Steve Hill

Steve serves on the LEAF Board of Directors and is the Editor in Chief, coordinating the daily news articles and social media content of the organization. He is an active journalist in the aging research and biotechnology field and has to date written over 500 articles on the topic as well as attending various medical industry conferences. In 2019 he was listed in the top 100 journalists covering biomedicine and longevity research in the industry report – Top-100 Journalists covering advanced biomedicine and longevity created by the Aging Analytics Agency. His work has been featured in H+ magazine, Psychology Today, Singularity Weblog, Standpoint Magazine, and, Keep me Prime, and New Economy Magazine. Steve has a background in project management and administration which has helped him to build a united team for effective fundraising and content creation, while his additional knowledge of biology and statistical data analysis allows him to carefully assess and coordinate the scientific groups involved in the project. In 2015 he led the Major Mouse Testing Program (MMTP) for the International Longevity Alliance and in 2016 helped the team of the SENS Research Foundation to reach their goal for the OncoSENS campaign for cancer research.
Write a comment:

*

Your email address will not be published.

© 2018 - LIFE EXTENSION ADVOCACY FOUNDATION
Privacy Policy / Terms Of Use

       Powered by MMD